0.000USD0.000Pre-market 08/17, 09:30 (ET)
25.00MMarket Cap
0.06P/E TTM
ENLV Balance Sheet
You can check out the annual or quarterly balance sheets of Enlivex Therapeutics Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing ENLV stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Enlivex Therapeutics Ltd Have?
In its most recent quarterly, Enlivex Therapeutics Ltd had 1.89M in cash and cash equivalents.
How Much Are Enlivex Therapeutics Ltd's Total Liabilities?
Enlivex Therapeutics Ltd reported 392.05M in total liabilities as of the latest reported quarter, including 9.02M in current liabilities and 383.03M in non-current liabilities.
What Are Enlivex Therapeutics Ltd's Total Assets?
As of the latest reported quarter, Enlivex Therapeutics Ltd's total assets were 2.33B, consisting of 1.74B in current assets and 583.82M in non-current assets.
How Much Shareholders' Equity Does Enlivex Therapeutics Ltd Have?
Enlivex Therapeutics Ltd reported 1.93B in total shareholders' equity as of the latest reported quarter.